Healthy Extracts Inc. (HYEX) Stands Distinct in the Development, Provision of Highest-Quality Supplements with Proven Health Benefits

June 14, 2021 11:42:15
  • HYEX’s portfolio of wholly owned subsidiaries currently comprises BergametNA and Ultimate Brain Nutrients
  • BergametNA, whose products target cardiovascular and immune health, sources its formulations from the Citrus Bergamot SuperFruit(TM)
  • The bergamot fruit is richly packed with polyphenolic flavanones, which are known to decrease bad cholesterol, triglyceride, and glucose, as well as increase the good cholesterol
  • BergaMet only uses the highest concentration of polyphenolic flavanones (“BPF”) as the higher the BPF, the greater the effectiveness of the supplement
Guided by the philosophy ‘Live Life Young Again’ and its commitment to superior health technology by engaging in the R&D of natural plant-based formulations, Healthy Extracts (OTCQB: HYEX), through its portfolio of wholly owned subsidiaries that currently comprises Ultimate Brain Nutrients (“UBN”) and BergametNA, develops, sells, and distributes proprietary products with proven health benefits. As UBN creates formulations that improve brain health, including memory, cognition, focus, and neuro-energy, BergametNA’s focus is primarily on the development of powerfully proven supplements, sourced from the Citrus Bergamot SuperFruit(TM) (“bergamot”) and which target cardiovascular and immune health. Native to the Calabria region of Southern Italy, bergamot has a host of health benefits as it is a source of high concentrations of polyphenolic flavanones, measured in terms of the bergamot polyphenolic fraction (“BPF”). According to Dr. Gerald Haase, MD, a clinical professor of surgery at the University of Colorado School of Medicine, the BPF in bergamots ranges from 30% to 47% ( The fruit’s five key polyphenolic flavanones perform the following specific actions that offer human health benefits:
  • They activate AMP kinase, which is a master regulator of glucose and fatty acid metabolism
  • By acting like HMG-CoA reductase inhibitors (“statins”), they block the mevalonate pathway (“MP”), which is known to synthesize cholesterol, thereby decreasing the amount of cholesterol made in the body
  • They inhibit phosphodiesterase 3B, thus improving cardiac and overall performance by promoting vasodilation (blood vessel dilation) and smooth relaxation of the heart and lung muscles
Bergamot’s polyphenolic flavanones act just like statins and even have similar health benefits. However, while statins are known to cause side effects, some potentially severe, the compounds drawn from bergamots and, by extension, the supplements are considered safer and better. Further, more than a dozen clinical studies and independent research have proven bergamot’s benefits as regards its ability to deal with cardiovascular disease, metabolic syndrome, and non-alcoholic fatty liver disease. Summarizing some of the findings, Dr. Haase noted: “With regard to metabolic syndrome, with or without fatty liver disease… total cholesterol and LDL cholesterol go down 25-35%, triglycerides go down more than 30%, glucose goes down around 20%, and the good cholesterol goes up by up to 40%.” “In non-alcoholic fatty liver disease, there is dramatic improvement in dyslipidemia, decrease in oxidative damages, and there are decreases in liver enzyme levels. Glucose metabolism is also enhanced,” Dr. Haase added. Dr. Haase further observes that the higher the BPF, the greater the supplement’s effectiveness. With BergametNA only using the bergamots with the highest BPF (47%), customers are guaranteed to extract more out of the powerfully proven plant-based supplements than from competitors’ products, which are sourced from bergamots whose BPF concentrations range between 30% and 37% ( When Healthy Extracts Inc. (HYEX) formally changed its name from Grey Cloak Tech Inc. early this year, its resolve to primarily develop plant-based, proprietary nutraceuticals and neuro-products was clear. This commitment indeed continues and is embodied by the effective supplements the company continues to avail to its customers. For more information, visit the company’s website at NOTE TO INVESTORS: The latest news and updates relating to HYEX are available in the company’s newsroom at About Healthy Extracts Inc. “Live Life Young Again” Healthy Extracts Inc. (OCTQB: HYEX) serves as a platform for developing and acquiring complementary companies that feature science-forward, clinically proven, plant-based and proprietary products in select high-margin and high-growth categories within the multibillion-dollar nutraceuticals market – the first two multimillion-dollar examples of which have already been launched. Company subsidiaries BergametNA(TM) and Ultimate Brain Nutrients(TM) (“UBN”) are providers of nutraceutical natural heart and brain health supplements, including the only heart health supplement containing Citrus Bergamot SuperFruit(TM), the highest quality and concentration of polyphenols and flavonoids available anywhere in the world and exclusive to BergametNA in North America and backed by 17 clinical studies. UBN’s KETONOMICS(R) proprietary formulations improve brain health, including memory, cognition, focus and neuro-energy, and have multiple intellectual property license opportunities for monetizing the company’s portfolio. UBN has six unique formulation patents – two issued and four pending. For more information, visit: or Forward-Looking Statements and Safe Harbor Notice All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2020, and future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release. Healthy Extracts Inc. Las Vegas, Nevada 720-463-1004 Corporate Communications: InvestorBrandNetwork (“IBN”) Los Angeles, California 310.299.1717 Office About BioMedWire BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge. To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only) For more information, please visit Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: BioMedWire (BMW) San Francisco, California 415.949.5050 Office BioMedWire is part of the InvestorBrandNetwork.